Loading clinical trials...
Loading clinical trials...
Effect of Financial Incentives on Weight Loss in Patients With Failed Bariatric Surgery: A Multicenter Randomized Open-Label Trial
This national, prospective, multicenter, and randomized study seeks to evaluate the effect of financial incentives on weight loss in individuals who experience weight regain following bariatric surgery. The study also aims to conduct a cost-utility analysis to measure the effectiveness of the intervention and assess the potential budgetary implications if it were to be implemented on a wider scale.
Our intervention is based on the principle of "contingency management" whereby financial rewards are contingent upon meeting specific weight loss targets. To assess the effectiveness of this approach, patients who have experienced weight regain after bariatric surgery will be randomly assigned to one of three groups. Group 1 will receive the standard care that includes setting a weight-loss target based on the weight achieved at 12 months post-bariatric surgery following the standard multidisciplinary follow-up at the inclusion center. Group 2 will receive the same treatment as the control group (Group 1), but with an additional financial incentive if the weight loss target (corresponding to the weight they reached 12 months after bariatric surgery) is achieved 12 months after inclusion. Group 3 will receive the same treatment as the control group (Group 1), but the financial incentive will be proportional to the actual weight loss achieved relative to the weight loss target (corresponding to the weight they reached 12 months after bariatric surgery). The study will include a standard post-bariatric surgery follow-up visits scheduled at 6, 12, 18, and 24 months, as per routine practice. At the 12-month visit, participants will be eligible to receive a financial incentive based on their arm assignment and the extent of weight loss achieved. After the 12-month visit, participants will not receive any additional financial incentives until the 24-month visit.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
AP-HP - hôpital Avicenne
Bobigny, France
AP-HP - hôpital Louis-Mourier
Colombes, France
Centre hospitalier intercommunal de Créteil
Créteil, France
AP-HM - hôpital de la Conception
Marseille, France
CHU de Nantes - hôpital Laënnec
Nantes, France
CHR d'Orléans - hôpital La Source
Orléans, France
AP-HP - hôpital de la Pitié-Salpêtrière
Paris, France
AP-HP - hôpital européen Georges-Pompidou
Paris, France
AP-HP - hôpital Bichat - Claude-Bernard
Paris, France
CHU de Poitiers
Poitiers, France
Start Date
April 1, 2025
Primary Completion Date
April 1, 2028
Completion Date
April 1, 2029
Last Updated
April 4, 2025
264
ESTIMATED participants
Control
OTHER
Threshold financial incentive
BEHAVIORAL
Proportional financial incentive
BEHAVIORAL
Lead Sponsor
Assistance Publique - Hôpitaux de Paris
Collaborators
NCT01143454
NCT07472881
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions